Planned enrollment increased by 300 participants
Before: 600 participants (planned). After: 900 participants (planned).
Study sponsor: Summit Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 600 participants (planned). After: 900 participants (planned).